SEI Investments
CGON icon

SEI Investments’s CG Oncology CGON Stock Holding History

SEI Investments’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
15,940
-2,149
-12% -$140K ﹤0.01% 2237
2026
Q1 		$1.22M Buy
18,089
+9,542
+112% +$541K ﹤0.01% 2254
2025
Q4 		$355K Buy
8,547
+266
+3% +$11K ﹤0.01% 2655
2025
Q3 		$334K Buy
8,281
+238
+3% +$6.92K ﹤0.01% 2420
2025
Q2 		$209K Buy
+8,043
New +$194K ﹤0.01% 2551

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SEI Investments's CGON Position: Q2 2026 in Review

SEI Investments reduced its CG Oncology (CGON) stake by 12% in Q2 2026, selling an estimated $140K and leaving 15,940 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2237.

SEI Investments first reported a position in CGON in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.22M in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • SEI Investments held 15,940 shares of CG Oncology worth $1.13M as of Q2 2026.
  • SEI Investments sold 2,149 CG Oncology shares in Q2 2026, an estimated $140K.
  • CG Oncology made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2237 holding.
  • SEI Investments first reported a position in CG Oncology in Q2 2025 and has held it in 5 quarters since.
  • SEI Investments's CG Oncology position peaked at $1.22M in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.